Cargando…
A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693535/ https://www.ncbi.nlm.nih.gov/pubmed/33147863 http://dx.doi.org/10.3390/metabo10110443 |
_version_ | 1783614766958247936 |
---|---|
author | Olesova, Dominika Galba, Jaroslav Piestansky, Juraj Celusakova, Hana Repiska, Gabriela Babinska, Katarina Ostatnikova, Daniela Katina, Stanislav Kovac, Andrej |
author_facet | Olesova, Dominika Galba, Jaroslav Piestansky, Juraj Celusakova, Hana Repiska, Gabriela Babinska, Katarina Ostatnikova, Daniela Katina, Stanislav Kovac, Andrej |
author_sort | Olesova, Dominika |
collection | PubMed |
description | Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years or even more which adversely affects a child’s perspective. A laboratory method allowing to detect the disorder at earlier stages is of a great need, as this could help the patients to start with treatment at a younger age, even prior to the clinical diagnosis. Recent evidence indicates that metabolomic markers should be considered as diagnostic markers, also serving for further differentiation and characterization of different subgroups of the autism spectrum. In this study, we developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry method for the simultaneous determination of six metabolites in human urine. These metabolites, namely methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate and xanthurenic acid were selected as potential biomarkers according to prior metabolomic studies. The analysis was carried out by means of reversed-phase liquid chromatography with gradient elution. Separation of the metabolites was performed on a Phenomenex Luna(®) Omega Polar C18 (100 × 1.0 mm, 1.6 µm) column at a flow rate of 0.15 mL/min with acetonitrile/water 0.1% formic acid aqueous as the mobile phase. The analysis was performed on a group of children with autism spectrum disorder and age-matched controls. In school children, we have detected disturbances in the levels of oxidative stress markers connected to arginine and purine metabolism, namely methylguanidine and N-acetylargine. Also, products of gut bacteria metabolism, namely indoxyl sulfate and indole-3-acetic acid, were found to be elevated in the patients’ group. We can conclude that this newly developed method is fast, sensitive, reliable, and well suited for the quantification of proposed markers. |
format | Online Article Text |
id | pubmed-7693535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76935352020-11-28 A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder Olesova, Dominika Galba, Jaroslav Piestansky, Juraj Celusakova, Hana Repiska, Gabriela Babinska, Katarina Ostatnikova, Daniela Katina, Stanislav Kovac, Andrej Metabolites Article Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years or even more which adversely affects a child’s perspective. A laboratory method allowing to detect the disorder at earlier stages is of a great need, as this could help the patients to start with treatment at a younger age, even prior to the clinical diagnosis. Recent evidence indicates that metabolomic markers should be considered as diagnostic markers, also serving for further differentiation and characterization of different subgroups of the autism spectrum. In this study, we developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry method for the simultaneous determination of six metabolites in human urine. These metabolites, namely methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate and xanthurenic acid were selected as potential biomarkers according to prior metabolomic studies. The analysis was carried out by means of reversed-phase liquid chromatography with gradient elution. Separation of the metabolites was performed on a Phenomenex Luna(®) Omega Polar C18 (100 × 1.0 mm, 1.6 µm) column at a flow rate of 0.15 mL/min with acetonitrile/water 0.1% formic acid aqueous as the mobile phase. The analysis was performed on a group of children with autism spectrum disorder and age-matched controls. In school children, we have detected disturbances in the levels of oxidative stress markers connected to arginine and purine metabolism, namely methylguanidine and N-acetylargine. Also, products of gut bacteria metabolism, namely indoxyl sulfate and indole-3-acetic acid, were found to be elevated in the patients’ group. We can conclude that this newly developed method is fast, sensitive, reliable, and well suited for the quantification of proposed markers. MDPI 2020-11-02 /pmc/articles/PMC7693535/ /pubmed/33147863 http://dx.doi.org/10.3390/metabo10110443 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Olesova, Dominika Galba, Jaroslav Piestansky, Juraj Celusakova, Hana Repiska, Gabriela Babinska, Katarina Ostatnikova, Daniela Katina, Stanislav Kovac, Andrej A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder |
title | A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder |
title_full | A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder |
title_fullStr | A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder |
title_full_unstemmed | A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder |
title_short | A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder |
title_sort | novel uhplc-ms method targeting urinary metabolomic markers for autism spectrum disorder |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693535/ https://www.ncbi.nlm.nih.gov/pubmed/33147863 http://dx.doi.org/10.3390/metabo10110443 |
work_keys_str_mv | AT olesovadominika anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT galbajaroslav anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT piestanskyjuraj anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT celusakovahana anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT repiskagabriela anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT babinskakatarina anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT ostatnikovadaniela anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT katinastanislav anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT kovacandrej anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT olesovadominika noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT galbajaroslav noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT piestanskyjuraj noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT celusakovahana noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT repiskagabriela noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT babinskakatarina noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT ostatnikovadaniela noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT katinastanislav noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder AT kovacandrej noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder |